PRESS RELEASE published on 05/13/2024 at 17:58, 6 months 10 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase of 83,771 ordinary shares for cancellation, highest price at 82.00p, lowest at 80.60p, and volume weighted average price at 81.7994p London Stock Exchange Ordinary Shares Share Buyback Cancellation Funding Circle Plc
BRIEF published on 05/09/2024 at 18:42, 6 months 14 days ago Funding Circle Plc Completes Share Buyback Transaction London Stock Exchange Share Buyback Market Abuse Regulation Numis Securities Funding Circle
PRESS RELEASE published on 05/09/2024 at 18:37, 6 months 14 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces buy-back of 250,000 ordinary shares at prices between 71.00p and 77.20p, with a volume-weighted average price of 73.8359p per share London Stock Exchange Ordinary Shares Share Buyback Program Funding Circle Plc Buy-back
BRIEF published on 05/08/2024 at 18:24, 6 months 15 days ago Funding Circle Plc: Details on Recent Share Buyback Share Buyback Investment Stock Market LSE Funding Circle
PRESS RELEASE published on 05/08/2024 at 18:19, 6 months 15 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc cancels 126,704 ordinary shares as part of buy-back program. Company's issued share capital now at 355,099,011 shares. Detailed transaction information provided Share Capital Ordinary Shares Buy-back Program Funding Circle Plc Transaction Details
BRIEF published on 05/03/2024 at 18:21, 6 months 20 days ago Funding Circle Holdings plc Announces Share Buyback Transaction Details London Stock Exchange Share Buyback Capital Management Funding Circle Stock Cancellation
PRESS RELEASE published on 05/03/2024 at 18:16, 6 months 20 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 200,000 ordinary shares, enhancing shareholder value London Stock Exchange Shareholder Value Share Purchase Cancellation Funding Circle Plc
BRIEF published on 05/02/2024 at 18:05, 6 months 21 days ago Funding Circle Plc Announces Share Buyback Transaction Share Buyback Corporate Governance Financial Markets Stock Transactions Funding Circle
PRESS RELEASE published on 05/02/2024 at 18:00, 6 months 21 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase of 35,115 ordinary shares for cancellation at 69.00p each, as part of buy-back program, on 02 May 2024 London Stock Exchange Ordinary Shares Buy-back Program Cancellation Funding Circle Plc
BRIEF published on 05/01/2024 at 18:23, 6 months 22 days ago Funding Circle Holdings plc Completes Share Buyback Transaction London Stock Exchange Share Buyback Stock Market Share Cancellation Funding Circle
Published on 11/22/2024 at 23:55, 21 hours 46 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 22 hours 11 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 22 hours 36 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 23 hours 11 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 3 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 3 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 4 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 2 days 14 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 2 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 3 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 3 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
